| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/27/2009 | US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 10/27/2009 | US7608424 Process for production of a recombinant protein and a fusion protein |
| 10/27/2009 | US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 10/27/2009 | US7608268 Ferritin fusion proteins for use in vaccines and other applications |
| 10/22/2009 | WO2009102357A3 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 10/22/2009 | WO2009099777A3 Chimeric hiv fusion proteins as vaccines |
| 10/22/2009 | US20090264627 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents |
| 10/22/2009 | US20090264624 Human cytokine receptor |
| 10/22/2009 | US20090264618 Compounds With a Branched Linker |
| 10/22/2009 | US20090264370 Polypeptides homologous to vegf and bmp1 |
| 10/22/2009 | US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases |
| 10/22/2009 | US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 10/22/2009 | US20090263879 Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples |
| 10/21/2009 | EP2110434A1 Type-1 cytokine receptor GLM-R |
| 10/21/2009 | EP1499885B1 Novel fusion proteins and assays for molecular binding |
| 10/21/2009 | EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 10/21/2009 | EP1392359B1 Specific binding proteins and uses thereof |
| 10/21/2009 | EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 10/20/2009 | US7605246 Genes differentially expressed in breast cancer |
| 10/20/2009 | US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 10/20/2009 | US7605233 Tumour necrosis factor binding ligands |
| 10/20/2009 | US7604931 Cripto mutant and uses thereof |
| 10/15/2009 | WO2009125231A2 Anti-atheroma vaccine |
| 10/15/2009 | US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same |
| 10/15/2009 | CA2758213A1 Anti-atheroma vaccine |
| 10/15/2009 | CA2721093A1 Human serum albumin linkers and conjugates thereof |
| 10/15/2009 | CA2720748A1 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (dnl) technology |
| 10/14/2009 | EP2108126A2 Pathogen binding |
| 10/14/2009 | EP1554572B1 Compositions and methods for modulating blood-brain barrier transport |
| 10/14/2009 | EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 10/14/2009 | EP1230268B1 Heteroclitic analogs of class i epitopes |
| 10/14/2009 | CN101555483A Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof |
| 10/14/2009 | CN101555482A Fusion protein of human parathyrine (1-34) diad and human seralbumin and preparation thereof |
| 10/14/2009 | CN101555284A Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof |
| 10/14/2009 | CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system |
| 10/13/2009 | US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy |
| 10/13/2009 | US7601813 Anti-GL50 antibodies |
| 10/08/2009 | WO2009121804A1 Drug fusions and conjugates |
| 10/08/2009 | US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 10/08/2009 | US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 10/08/2009 | US20090252705 IL-6/IL-6R Fusion Protein |
| 10/08/2009 | CA2719361A1 Multizymes |
| 10/08/2009 | CA2718480A1 Drug fusions and conjugates |
| 10/07/2009 | EP2106446A1 Stabilization of cyclic peptide structures |
| 10/07/2009 | EP2106442A1 Cancerous disease modifying antibodies |
| 10/07/2009 | EP2106441A1 Cancerous disease modifying antibodies |
| 10/07/2009 | EP1434791B1 Specific binding agents of human angiopoietin-2 |
| 10/07/2009 | EP0907730B1 Haemopoietin receptor and genetic sequences encoding same |
| 10/07/2009 | CN101550193A Novel IZ-shGITRL fusion protein and preparation method and application thereof |
| 10/07/2009 | CN100547003C Antibodies to human IL-1 beta |
| 10/06/2009 | US7598352 Method of identifying polypeptide monobodies which bind to target proteins and use thereof |
| 10/06/2009 | US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells |
| 10/06/2009 | US7597894 Antigen presenting cells and dendritic cells; inducing immunology response |
| 10/06/2009 | US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma |
| 10/06/2009 | CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 10/06/2009 | CA2218129C Chimeric mcp and daf proteins with cell surface localizing domain |
| 10/06/2009 | CA2111205C Polypeptides having kinase activity, their preparation and use |
| 10/01/2009 | WO2009120893A2 Polypeptide-polymer conjugates and methods of use thereof |
| 10/01/2009 | WO2009120396A2 Compositions and methods for regulating erythropoientin expression and ameliorating anemia and stimulating erythropoiesis |
| 10/01/2009 | WO2009119662A1 Peptide capable of inducing autophagic cell death |
| 10/01/2009 | WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor |
| 10/01/2009 | WO2009118778A1 Method of separating fish immature germ cell using fish immature germ cell surface-specific protein |
| 10/01/2009 | WO2009100127A3 Isolated brca1 peptides and method of use |
| 10/01/2009 | WO2009099961A3 Engineered antibody constant domain molecules |
| 10/01/2009 | US20090246827 Recombinant toxin fragments |
| 10/01/2009 | US20090246215 Amyloid beta1-6 antigen arrays |
| 10/01/2009 | US20090246214 Fusion proteins containing recombinant cytotoxic rnases |
| 10/01/2009 | US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 10/01/2009 | US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 09/30/2009 | EP2105503A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains |
| 09/30/2009 | EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
| 09/30/2009 | EP1451322B1 Il-21 antagonists |
| 09/30/2009 | EP1328297B1 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 09/30/2009 | CN101544697A Fusion protein TT-B7-H4IgV as well as preparation method and application thereof |
| 09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
| 09/30/2009 | CN100545261C Novel phospholipases and uses thereof |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/29/2009 | US7595376 Poly zinc finger proteins with improved linkers |
| 09/29/2009 | US7595375 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 09/29/2009 | US7595175 Polyketides and their synthesis |
| 09/29/2009 | US7595166 Methods of screening modulators of T2R taste receptors |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595053 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
| 09/24/2009 | WO2009089186A3 Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
| 09/24/2009 | WO2009079564A3 Immunogenic compositions and methods of use thereof |
| 09/24/2009 | WO2009079053A3 High affinity metal-oxide binding peptides with reversible binding |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239264 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | DE102008014882A1 New fusion peptide comprising a coupling of a silencing domain with small molecule peptide aptamer, is androgen receptor inhibitor, useful to treat prostate cancer and benign prostatic hyperplasia |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP1863850B1 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 09/23/2009 | EP1003781B1 Interleukin-18 binding proteins, their preparation and use |